APOBEC3A catalyzes mutation and drives carcinogenesis in vivo.

MLA

Law, Emily K., et al. “APOBEC3A Catalyzes Mutation and Drives Carcinogenesis in Vivo.” The Journal of Experimental Medicine, vol. 217, no. 12, Dec. 2020. EBSCOhost, https://doi.org/10.1084/jem.20200261.

APA

Law, E. K., Levin-Klein, R., Jarvis, M. C., Kim, H., Argyris, P. P., Carpenter, M. A., Starrett, G. J., Temiz, N. A., Larson, L. K., Durfee, C., Burns, M. B., Vogel, R. I., Stavrou, S., Aguilera, A. N., Wagner, S., Largaespada, D. A., Starr, T. K., Ross, S. R., & Harris, R. S. (2020). APOBEC3A catalyzes mutation and drives carcinogenesis in vivo. The Journal of Experimental Medicine, 217(12). https://doi.org/10.1084/jem.20200261

Chicago

Law, Emily K, Rena Levin-Klein, Matthew C Jarvis, Hyoung Kim, Prokopios P Argyris, Michael A Carpenter, Gabriel J Starrett, et al. 2020. “APOBEC3A Catalyzes Mutation and Drives Carcinogenesis in Vivo.” The Journal of Experimental Medicine 217 (12). doi:10.1084/jem.20200261.